Table 3.

Treatment-related adverse events in patients treated with nivolumab

Event	Any grade	Grade 3 or 4
	Number of patients (%)
Fatigue / Malaise	5 (12%)	1 (2%)
Fever	4 (10%)	3 (7%)
Rash / Skin Toxicity	4 (10%)	2 (5%)
Hypothyroidism	3 (7%)	0
Diarrhea	2 (5%)	1 (2%)
Arthralgia	2 (5%)	0
Myalgia / Myositis	2 (5%)	0
Adrenal Insufficiency	2 (5%)	0
Peripheral Edema	2 (5%)	0
Heart Block (3rd degree)	1 (2%)	1 (2%)
Respiratory Failure	1 (2%)	1 (2%)
Headache	1 (2%)	1 (2%)
Aphasia	1 (2%)	0
Infusion Reaction	1 (2%)	0
Diabetes	1 (2%)	0
Uveitis	1 (2%)	0
Hypertension	1 (2%)	0
Hypophysitis	1 (2%)	0
Cough	1 (2%)	0
Lymphadenopathy	1 (2%)	0
Back Pain	1 (2%)	0